Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Author(s) -
Jes Olesen,
HansChristoph Diener,
Ingo W. Husstedt,
Peter J. Goadsby,
David B. Hall,
Ulrich Meier,
Stephane Pollentier,
Lynna M. Lesko
Publication year - 2004
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa030505
Subject(s) - calcitonin gene related peptide , migraine , antagonist , medicine , calcitonin , receptor antagonist , receptor , pharmacology , calcitonin receptor , endocrinology , neuropeptide
Calcitonin gene-related peptide (CGRP) may have a causative role in migraine. We therefore hypothesized that a CGRP-receptor antagonist might be effective in the treatment of migraine attacks.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom